Results of a study to determine the effects of three oral contraceptives on serum lipoprotein levels.
Fertil Steril
; 38(5): 559-63, 1982 Nov.
Article
en En
| MEDLINE
| ID: mdl-7128841
ABSTRACT
A multicenter, double-blind investigation with random allocations of subjects to Ortho-Novum 1/50 tablets, Ortho-Novum 1/35 tablets, or Modicon tablets (Ortho Pharmaceutical Corporation, Raritan, NJ) was conducted. Each subject remained on the same oral contraceptive (OC) for at least four cycles. Serum high-density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, triglyceride, and cholesterol were measured prior to the initiation of OC therapy and were repeated after treatment cycles 2 and 4. There were no significant changes in HDL, LDL, or serum cholesterol levels. Triglyceride levels increased but remained significant only with the lowest dose product. These were no significant differences among the three drugs for the four parameters studied.
Palabras clave
Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Double-blind Studies; Ethinyl Estradiol; Family Planning; Lipid Metabolic Effects; Lipids; Mestranol; Norethindrone; Oral Contraceptives--side effects; Physiology; Population Characteristics; Reproductive Control Agents; Research Methodology; Studies
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Anticonceptivos Orales
/
Anticonceptivos Orales Combinados
/
Lipoproteínas
Tipo de estudio:
Clinical_trials
Límite:
Adolescent
/
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Fertil Steril
Año:
1982
Tipo del documento:
Article